Poitiers, France

Christian Rogier

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université De Poitiers. Active years: 2011.


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christian Rogier: Innovator in Smooth Muscle Cell Treatment

Introduction

Christian Rogier is a notable inventor based in Poitiers, France. He has made significant contributions to the field of medical treatments, particularly focusing on conditions related to smooth muscle cell constriction. His innovative approach has the potential to impact the treatment of various diseases.

Latest Patents

Christian Rogier holds a patent for the use of benzo[c]quinolizinium derivatives for the treatment of diseases linked to smooth muscle cell constriction. This invention addresses critical health issues such as hypertension and asthma, providing a new avenue for therapeutic intervention. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Christian has worked with esteemed institutions, including the Centre National de la Recherche Scientifique and Université de Poitiers. His roles in these organizations have allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.

Collaborations

Christian has collaborated with notable colleagues, including Frédéric Becq and Renaud Robert. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Christian Rogier's innovative work in the treatment of diseases related to smooth muscle cell constriction highlights his dedication to improving healthcare. His contributions are paving the way for new therapeutic options that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…